ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,361, issued on April 21, was assigned to Enveric Biosciences Canada Inc. (Calgary, Canada).
"Carboxylated psilocybin derivatives and methods of using" was invented by Jillian M. Hagel (Calgary, Canada), Peter J. Facchini (Calgary, Canada) and Chang-Chun Ling (Calgary, Canada).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are novel carboxylated psilocybin derivative compounds and pharmaceutical and recreational drug formulations containing the same. The compounds may be produced by reacting a reactant psilocybin derivative with a carboxyl or Carboxylic acid derivative containing compound."
The patent was filed on July 28, 2023, under Appl...